Emirates Drug Establishment bans veterinary use of ciprofloxacin from November 1
Published · Updated
What happened
The Emirates Drug Establishment announced within the past 24 hours that ciprofloxacin will no longer be permitted for veterinary use in the UAE from 2026-11-01. The regulator linked the decision to antimicrobial resistance evidence and said the ban is aimed at reducing pressure on a treatment used in human medicine.
Why it matters
This is a binding domestic antimicrobial stewardship action by a UAE regulator, not a research finding or advisory. It changes what veterinary providers and livestock operators can buy, stock, prescribe, and administer within days, and it may require substitution to other treatments and compliance checks before the effective date.
The Emirates Drug Establishment announced a ban on the use of ciprofloxacin in the UAE veterinary sector, with the measure taking effect on 2026-11-01. EDE said the step follows a scientific assessment of antimicrobial resistance data, including studies submitted by United Arab Emirates University, and is intended to preserve the antibiotic's effectiveness for human medicine. The move creates an immediate implementation task for veterinary suppliers, clinics, farms, and enforcement agencies ahead of the start date.
Watch for
Emirates Drug Establishment publication of implementing guidance for veterinary distributors and clinics before 2026-10-24 UAE Ministry of Climate Change and Environment circular to livestock farms and veterinary practices naming permitted substitute antibiotics by 2026-10-24 Major UAE veterinary wholesalers' catalog or stock notices showing ciprofloxacin product withdrawal in the UAE market by 2026-10-24 No Emirates Drug Establishment notice of a grace period or exemption before 2026-10-24
Sources
Researched and written by AI from the sources listed, under published rules. How V³ Aware is made